Approval of Low-blood Pressure Drug may be Cancelled by the FDA

Aug 17, 10

Share Midodrine hydrochloride, the low blood pressure medicine, must be taken off the United State market for the reason that it required post-approval researches to confirm the medical advantage of the drug have not been completed, says the Food and Drug Administration. The medicine, promoted under the brand name ProAmatine by...